Ken Iozumi

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Improvement of pruritus with baricitinib in a patient with prurigo nodularis refractory to multiple biologic therapies.

Improvement of pruritus with baricitinib in a patient with prurigo nodularis refractory to multiple biologic therapies.

Journal: European journal of dermatology : EJD

Published: August 31, 2026

Response to letter regarding…letter to the editor-Evaluation of the clinical applicability of artificial intelligence in determining systemic therapy indications and treatment selection in psoriasis.

Response to letter regarding…letter to the editor-Evaluation of the clinical applicability of artificial intelligence in determining systemic therapy indications and treatment selection in psoriasis.

Journal: The Journal of dermatological treatment

Published: August 04, 2026

Nemolizumab is associated with improved sleep duration and fewer nocturnal awakenings in patients with prurigo nodularis.

Nemolizumab is associated with improved sleep duration and fewer nocturnal awakenings in patients with prurigo nodularis.

Journal: JAAD international

Published: August 01, 2026

Letter: The Retrospective Analysis of the Association Between Longitudinal Thymus and Activation-regulated Chemokine Changes and Cutaneous Adverse Events in Patients with Prurigo Nodularis Treated with Nemolizumab.

Letter: The Retrospective Analysis of the Association Between Longitudinal Thymus and Activation-regulated Chemokine Changes and Cutaneous Adverse Events in Patients with Prurigo Nodularis Treated with Nemolizumab.

Journal: Dermatitis : contact, atopic, occupational, drug

Published: July 16, 2026

Evaluation of the clinical applicability of artificial intelligence in determining systemic therapy indications and treatment selection in psoriasis.

Evaluation of the clinical applicability of artificial intelligence in determining systemic therapy indications and treatment selection in psoriasis.

Journal: The Journal of dermatological treatment

Published: June 20, 2026

The Light and Shadow of Medical Mycology from the Perspective of a Return to the Origin.

The Light and Shadow of Medical Mycology from the Perspective of a Return to the Origin.

Journal: Medical mycology journal

Published: May 31, 2026

The Impact of Nemolizumab Treatment on the Systemic Inflammatory Indices in Patients With Prurigo Nodularis: A Retrospective Study With a Small Sample Size.

The Impact of Nemolizumab Treatment on the Systemic Inflammatory Indices in Patients With Prurigo Nodularis: A Retrospective Study With a Small Sample Size.

Journal: International journal of dermatology

Published: February 23, 2026

Dupilumab Can Be Effective for Immune-Related Adverse Event Dermatitis: A Case Report and Review of the Literature.

Dupilumab Can Be Effective for Immune-Related Adverse Event Dermatitis: A Case Report and Review of the Literature.

Journal: Clinical, cosmetic and investigational dermatology

Published: February 22, 2026

Acquired Digital Arteriovenous Malformation of the Toe Showing Tendency to Clinically Regress after Skin Biopsy: A Case Report.

Acquired Digital Arteriovenous Malformation of the Toe Showing Tendency to Clinically Regress after Skin Biopsy: A Case Report.

Journal: Case reports in dermatology

Published: February 20, 2026

Letter: Post-Marketing Efficacy of Nemolizumab for Prurigo Nodularis: A Single-Center Study with a Small Sample Size.

Letter: Post-Marketing Efficacy of Nemolizumab for Prurigo Nodularis: A Single-Center Study with a Small Sample Size.

Journal: Dermatitis : contact, atopic, occupational, drug

Published: February 06, 2026

24-week real world outcomes of nemolizumab in patients with prurigo nodularis.

24-week real world outcomes of nemolizumab in patients with prurigo nodularis.

Journal: The Journal of dermatological treatment

Published: February 03, 2026

Real-world Clinical Efficacy and Patient-reported Treatment Satisfaction of Nemolizumab Treatment in Prurigo Nodularis.

Real-world Clinical Efficacy and Patient-reported Treatment Satisfaction of Nemolizumab Treatment in Prurigo Nodularis.

Journal: Acta dermato-venereologica

Published: January 26, 2026

Showing 1-12 of 41

Last Updated: 09/26/2026